Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Polidocanol Foam Sclerotherapy in Symptomatic Internal Hemorrhoids: A Prospective Study

NCT07866248 is registered in ClinicalTrials.gov with Radwa Hussein Mohammed Hasanen as lead sponsor.

NCT NCT07866248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07866248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Polidocanol Foam Sclerotherapy in Symptomatic Internal Hemorrhoids: A Prospective Study
Lead sponsor
Radwa Hussein Mohammed Hasanen
Phase
Phase 4
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
September 1, 2028
Enrollment
130 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

internal hemorrhoids, internal piles sclerotherapy